Oral Oncolytics Will Require Health Care System to Adapt
Judging from the drug pipeline, the future of oncology is oral chemotherapy.
Related Articles
BGB-16673 Is Safe, Elicits Nearly 85% ORR in Relapsed/Refractory CLL/SLL
BGB-16673 showed a favorable safety profile and promising antitumor activity in relapsed/refractory CLL/SLL, with responses seen across baseline mutations.
Early Daratumumab in Patients With Myeloma Experiencing MRD Relapse Delays Clinical Progression
PREDATOR-MRD data can serve as proof of concept for larger trials with novel MRD assessment techniques.
Anito-Cel Drives Durable Responses in R/R Multiple Myeloma
Anitocabtagene autoleucel yielded an overall response rate of 97% in relapsed/refractory multiple myeloma.
IRAKLIA Data Support Subcutaneous Isatuximab as a SOC Administration Approach in Myeloma
The IRAKLIA study examined the use of an innovative on-body injector for isatuximab administration in multiple myeloma.
Addition of Dasatinib to Induction/Consolidation Fails to Boost Survival in Core-Binding Factor AML
Dasatinib added to induction and consolidation, then continued as maintenance, did not improve survival in core-binding factor AML.
FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer
FF-10832—an investigational liposomal formulation of gemcitabine—has received orphan drug designation from the FDA for biliary tract cancer.
AlloHSCT in AML: When, Why, and for Whom?
Panelists discuss how identifying appropriate candidates for allogeneic hematopoietic stem cell transplantation (alloHSCT) in acute myeloid leukemia (AML) involves evaluating remission status, relapse risk based…
Bria-IMT Plus Checkpoint Inhibition Leads to 52% 1-Year OS Rate in Heavily Pretreated Metastatic Breast Cancer
Bria-IMT plus checkpoint inhibition displayed a potential overall survival benefit in heavily pretreated, hormone receptor–positive breast cancer.
ESMO Gastrointestinal Cancers Congress
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Genomic Testing in Breast Cancer: Clinical Applications and Best Practices
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.